Market Cap 1.33B
Revenue (ttm) 534.53M
Net Income (ttm) -11.45M
EPS (ttm) N/A
PE Ratio 876.00
Forward PE 2,628.00
Profit Margin -2.14%
Debt to Equity Ratio 0.12
Volume 573,531
Avg Vol 727,204
Day's Range N/A - N/A
Shares Out 50.64M
Stochastic %K 29%
Beta 1.28
Analysts Strong Sell
Price Target $47.00

Company Profile

AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally. It offers Isolator Synergy Ablation System clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, a single-use disposable RF products for the treatmen...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 513 755 4100
Fax: 513 755 4567
Address:
7555 Innovation Way, Mason, United States
RocketThief
RocketThief May. 13 at 8:16 PM
$ATRC this is one of those classic cases of excellent company -> only a few hundred ST followers.
0 · Reply
RocketThief
RocketThief May. 13 at 5:32 PM
$ATRC these same conditions are basically true today. Reentering this very solid company
0 · Reply
MarketBeat
MarketBeat May. 12 at 7:11 PM
https://marketbeat.com/a/8650911/ $ATRC AtriCure Conference: New Devices, EnCompass Drive 2026 Growth Outlook
0 · Reply
Office21
Office21 May. 12 at 1:37 PM
$ATRC Ready and waiting for this one to rebound
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 5 at 8:06 PM
$ATRC Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.00 • Reported revenue of $141.25M up 14.26% YoY • AtriCure projects full year 2026 revenue of $600M to $610M, Adjusted EBITDA of $80M to $82M, and adjusted earnings per share between $0.00 and $0.04, expecting continued positive cash flow.
0 · Reply
Estimize
Estimize May. 5 at 3:00 PM
$ATRC reports after the close, Estimize Consensus +0.01 EPS and +0.72M Revs compared to WS http://www.estimize.com/atrc/fq1-2026?utm_conten
0 · Reply
SuperGreenToday
SuperGreenToday Apr. 29 at 9:52 AM
$ATRC Share Price: $28.47 Contract Selected: Oct 16, 2026 $25 Calls Buy Zone: $4.25 – $5.25 Target Zone: $7.34 – $8.97 Potential Upside: 63% ROI Time to Expiration: 169 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
maq34
maq34 Apr. 27 at 5:19 PM
$ATRC $JNJ $MDT $HIMS $PFE https://www.marketbeat.com/instant-alerts/filing-oak-harvest-investment-services-makes-new-148-million-investment-in-atricure-inc-atrc-2026-04-18/ https://www.marketbeat.com/instant-alerts/filing-oak-harvest-investment-services-makes-new-148-million-investment-in-atricure-inc-atrc-2026-04-18/
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 24 at 8:18 PM
$ATRC RSI: 50.55, MACD: -0.4608 Vol: 0.61, MA20: 28.65, MA50: 29.84 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
LewisDaKat
LewisDaKat Apr. 3 at 6:00 PM
$ATRC AtriCure (NASDAQ:ATRC) Stock Rating Upgraded by Freedom Capital https://marketwirenews.com/stock/atrc/news/atricure-nasdaq-atrc-stock-rating-upgraded-by-freedo-6407586195622607.html?utm_source=stocktwits
0 · Reply
Latest News on ATRC
AtriCure price target raised to $55 from $53 at Canaccord

2026-05-07T05:47:54.000Z - 6 days ago

AtriCure price target raised to $55 from $53 at Canaccord


AtriCure participates in a conference call with JPMorgan

2026-05-07T02:19:41.000Z - 6 days ago

AtriCure participates in a conference call with JPMorgan


AtriCure Earnings Call Transcript: Q1 2026

May 5, 2026, 4:30 PM EDT - 8 days ago

AtriCure Earnings Call Transcript: Q1 2026


AtriCure reports Q1 EPS ,0c consensus (6c)

2026-05-05T20:16:59.000Z - 8 days ago

AtriCure reports Q1 EPS ,0c consensus (6c)


AtriCure Reports First Quarter 2026 Financial Results

May 5, 2026, 4:01 PM EDT - 8 days ago

AtriCure Reports First Quarter 2026 Financial Results


AtriCure to Announce First Quarter 2026 Financial Results

Apr 14, 2026, 8:00 AM EDT - 4 weeks ago

AtriCure to Announce First Quarter 2026 Financial Results


AtriCure initiated with a Buy at Freedom Capital

2026-04-01T11:55:57.000Z - 6 weeks ago

AtriCure initiated with a Buy at Freedom Capital


AtriCure Transcript: The Citizens Life Sciences Conference 2026

Mar 10, 2026, 1:05 PM EDT - 2 months ago

AtriCure Transcript: The Citizens Life Sciences Conference 2026


AtriCure to Participate in the Citizens Life Sciences Conference

Feb 24, 2026, 8:00 AM EST - 2 months ago

AtriCure to Participate in the Citizens Life Sciences Conference


AtriCure price target lowered to $55 from $60 at UBS

2026-02-18T12:10:43.000Z - 3 months ago

AtriCure price target lowered to $55 from $60 at UBS


AtriCure price target lowered to $53 from $64 at Canaccord

2026-02-18T12:06:29.000Z - 3 months ago

AtriCure price target lowered to $53 from $64 at Canaccord

MDT


AtriCure downgraded to Perform from Outperform at Oppenheimer

2026-02-18T11:10:28.000Z - 3 months ago

AtriCure downgraded to Perform from Outperform at Oppenheimer


AtriCure price target lowered to $52 from $60 at Citizens

2026-02-18T10:50:16.000Z - 3 months ago

AtriCure price target lowered to $52 from $60 at Citizens


AtriCure Earnings Call Transcript: Q4 2025

Feb 17, 2026, 4:30 PM EST - 3 months ago

AtriCure Earnings Call Transcript: Q4 2025


AtriCure sees FY26 adjusted EPS 0c-4c, consensus (1c)

2026-02-17T21:13:22.000Z - 3 months ago

AtriCure sees FY26 adjusted EPS 0c-4c, consensus (1c)


AtriCure reports Q4 adjusted EPS 6c, consensus (11c)

2026-02-17T21:05:21.000Z - 3 months ago

AtriCure reports Q4 adjusted EPS 6c, consensus (11c)


AtriCure downgraded to Neutral from Overweight at JPMorgan

2026-02-11T10:15:26.000Z - 3 months ago

AtriCure downgraded to Neutral from Overweight at JPMorgan

EW MDT


AtriCure  sees FY26 revenue $600M-$610M, consensus $598.59M

2026-01-12T15:30:10.000Z - 4 months ago

AtriCure sees FY26 revenue $600M-$610M, consensus $598.59M


AtriCure price target raised to $48 from $42 at JPMorgan

2025-12-16T12:31:16.000Z - 5 months ago

AtriCure price target raised to $48 from $42 at JPMorgan


AtriCure Transcript: Stifel 2025 Healthcare Conference

Nov 12, 2025, 8:40 AM EST - 6 months ago

AtriCure Transcript: Stifel 2025 Healthcare Conference


AtriCure Transcript: UBS Global Healthcare Conference 2025

Nov 10, 2025, 2:00 PM EST - 6 months ago

AtriCure Transcript: UBS Global Healthcare Conference 2025


AtriCure Earnings Call Transcript: Q3 2025

Oct 29, 2025, 4:30 PM EDT - 7 months ago

AtriCure Earnings Call Transcript: Q3 2025


AtriCure reports Q3 EPS (1c), consensus (12c)

2025-10-29T20:06:39.000Z - 7 months ago

AtriCure reports Q3 EPS (1c), consensus (12c)


AtriCure to Participate in Upcoming Investor Conferences

Oct 27, 2025, 8:00 AM EDT - 7 months ago

AtriCure to Participate in Upcoming Investor Conferences


AtriCure to Announce Third Quarter 2025 Financial Results

Oct 8, 2025, 8:00 AM EDT - 7 months ago

AtriCure to Announce Third Quarter 2025 Financial Results


AtriCure Earnings Call Transcript: Q2 2025

Jul 29, 2025, 4:30 PM EDT - 10 months ago

AtriCure Earnings Call Transcript: Q2 2025


AtriCure to Announce Second Quarter 2025 Financial Results

Jul 8, 2025, 8:00 AM EDT - 11 months ago

AtriCure to Announce Second Quarter 2025 Financial Results


AtriCure Earnings Call Transcript: Q1 2025

Apr 29, 2025, 4:30 PM EDT - 1 year ago

AtriCure Earnings Call Transcript: Q1 2025


AtriCure Reports First Quarter 2025 Financial Results

Apr 29, 2025, 4:01 PM EDT - 1 year ago

AtriCure Reports First Quarter 2025 Financial Results


AtriCure to Announce First Quarter 2025 Financial Results

Apr 8, 2025, 8:00 AM EDT - 1 year ago

AtriCure to Announce First Quarter 2025 Financial Results


AtriCure Transcript: Investor Day 2025

Mar 26, 2025, 1:00 PM EDT - 1 year ago

AtriCure Transcript: Investor Day 2025


AtriCure to Host Analyst & Investor Day on March 26, 2025

Mar 12, 2025, 8:00 AM EDT - 1 year ago

AtriCure to Host Analyst & Investor Day on March 26, 2025


AtriCure Earnings Call Transcript: Q4 2024

Feb 12, 2025, 4:30 PM EST - 1 year ago

AtriCure Earnings Call Transcript: Q4 2024


AtriCure Transcript: Stifel 2024 Healthcare Conference

Nov 18, 2024, 9:10 AM EST - 1 year ago

AtriCure Transcript: Stifel 2024 Healthcare Conference


AtriCure Transcript: UBS Global Healthcare Conference

Nov 12, 2024, 8:00 PM EST - 1 year ago

AtriCure Transcript: UBS Global Healthcare Conference


AtriCure Earnings Call Transcript: Q3 2024

Oct 29, 2024, 4:30 PM EDT - 1 year ago

AtriCure Earnings Call Transcript: Q3 2024


AtriCure Reports Third Quarter 2024 Financial Results

Oct 29, 2024, 4:01 PM EDT - 1 year ago

AtriCure Reports Third Quarter 2024 Financial Results


AtriCure to Announce Third Quarter 2024 Financial Results

Oct 8, 2024, 8:00 AM EDT - 1 year ago

AtriCure to Announce Third Quarter 2024 Financial Results


AtriCure Receives CE-Mark for the EnCompass® Clamp

Oct 1, 2024, 8:00 AM EDT - 1 year ago

AtriCure Receives CE-Mark for the EnCompass® Clamp


AtriCure Earnings Call Transcript: Q2 2024

Jul 30, 2024, 4:30 PM EDT - 1 year ago

AtriCure Earnings Call Transcript: Q2 2024


AtriCure Reports Second Quarter 2024 Financial Results

Jul 30, 2024, 4:01 PM EDT - 1 year ago

AtriCure Reports Second Quarter 2024 Financial Results


AtriCure to Announce Second Quarter 2024 Financial Results

Jul 9, 2024, 8:00 AM EDT - 2 years ago

AtriCure to Announce Second Quarter 2024 Financial Results


AtriCure Earnings Call Transcript: Q1 2024

May 1, 2024, 4:30 PM EDT - 2 years ago

AtriCure Earnings Call Transcript: Q1 2024


AtriCure Reports First Quarter 2024 Financial Results

May 1, 2024, 4:01 PM EDT - 2 years ago

AtriCure Reports First Quarter 2024 Financial Results


AtriCure to Announce First Quarter 2024 Financial Results

Apr 10, 2024, 8:00 AM EDT - 2 years ago

AtriCure to Announce First Quarter 2024 Financial Results


AtriCure Earnings Call Transcript: Q4 2023

Feb 15, 2024, 4:30 PM EST - 2 years ago

AtriCure Earnings Call Transcript: Q4 2023


RocketThief
RocketThief May. 13 at 8:16 PM
$ATRC this is one of those classic cases of excellent company -> only a few hundred ST followers.
0 · Reply
RocketThief
RocketThief May. 13 at 5:32 PM
$ATRC these same conditions are basically true today. Reentering this very solid company
0 · Reply
MarketBeat
MarketBeat May. 12 at 7:11 PM
https://marketbeat.com/a/8650911/ $ATRC AtriCure Conference: New Devices, EnCompass Drive 2026 Growth Outlook
0 · Reply
Office21
Office21 May. 12 at 1:37 PM
$ATRC Ready and waiting for this one to rebound
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 5 at 8:06 PM
$ATRC Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.00 • Reported revenue of $141.25M up 14.26% YoY • AtriCure projects full year 2026 revenue of $600M to $610M, Adjusted EBITDA of $80M to $82M, and adjusted earnings per share between $0.00 and $0.04, expecting continued positive cash flow.
0 · Reply
Estimize
Estimize May. 5 at 3:00 PM
$ATRC reports after the close, Estimize Consensus +0.01 EPS and +0.72M Revs compared to WS http://www.estimize.com/atrc/fq1-2026?utm_conten
0 · Reply
SuperGreenToday
SuperGreenToday Apr. 29 at 9:52 AM
$ATRC Share Price: $28.47 Contract Selected: Oct 16, 2026 $25 Calls Buy Zone: $4.25 – $5.25 Target Zone: $7.34 – $8.97 Potential Upside: 63% ROI Time to Expiration: 169 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
maq34
maq34 Apr. 27 at 5:19 PM
$ATRC $JNJ $MDT $HIMS $PFE https://www.marketbeat.com/instant-alerts/filing-oak-harvest-investment-services-makes-new-148-million-investment-in-atricure-inc-atrc-2026-04-18/ https://www.marketbeat.com/instant-alerts/filing-oak-harvest-investment-services-makes-new-148-million-investment-in-atricure-inc-atrc-2026-04-18/
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 24 at 8:18 PM
$ATRC RSI: 50.55, MACD: -0.4608 Vol: 0.61, MA20: 28.65, MA50: 29.84 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
LewisDaKat
LewisDaKat Apr. 3 at 6:00 PM
$ATRC AtriCure (NASDAQ:ATRC) Stock Rating Upgraded by Freedom Capital https://marketwirenews.com/stock/atrc/news/atricure-nasdaq-atrc-stock-rating-upgraded-by-freedo-6407586195622607.html?utm_source=stocktwits
0 · Reply
SuperGreenToday
SuperGreenToday Apr. 1 at 2:21 PM
$ATRC Share Price: $28.79 Contract Selected: Oct 16, 2026 $25 Calls Buy Zone: $3.82 – $4.73 Target Zone: $7.07 – $8.64 Potential Upside: 75% ROI Time to Expiration: 197 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Paffcio1
Paffcio1 Mar. 7 at 7:04 AM
$ATRC Medinice (ICE.WA) – The $ATRC Disruptor? FDA Milestones. Keep an eye on this Polish medtech player disrupting surgical ablation & LAAO: • CoolCryo (FDA Cleared!): Uses Liquid Nitrogen, not nitrous oxide. 4-6x faster, better transmurality, works on beating heart. Tier-1 players already in the data room for M&A. • AtriClamp (LAAO Game Changer): Just filed FDA 510(k) Q-Sub for a polymer-based LAA clip. One LOI is already signed • 100% MRI Safe: Metal-free (unlike AtriClip/FLEX-Mini). No artifacts, perfect post-op diagnostics. • Unique Deployment: Extendable/sliding mechanism (not simple snap-fit) with a solid patent wall. • Scalability: Mass-produced via injection molding. Low COGS, massive margins. With a market cap <$100M, this is a textbook buyout target for $BSX or $MDT. Anyone else tracking this? #Medtech #Cardiology #ATRC #BSX #FDA #LAAO
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 4 at 5:09 AM
$ATRC RSI: 22.03, MACD: -1.7638 Vol: 2.55, MA20: 33.50, MA50: 37.11 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
RunnerSignals
RunnerSignals Feb. 25 at 7:05 PM
$PLAB $KMI $ATRC $BX $LTH watch the charts closely today as intraday patterns hint at rebounds and breakouts bottom line $BX looks most juicy https://stocksrunner.com/news/2026-02-25-intraday-technical-patterns-reveal-key-short-term-opportunities
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 20 at 4:15 PM
$ATRC Share Price: $33.38 Contract Selected: Jul 17, 2026 $35 Calls Buy Zone: $5.95 – $7.35 Target Zone: $11.08 – $13.54 Potential Upside: 76% ROI Time to Expiration: 146 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
OpenOutcrier
OpenOutcrier Feb. 18 at 1:24 PM
$ATRC (+3.7% pre) AtriCure (ATRC) Tops Q4 Earnings and Revenue Estimates https://ooc.bz/l/93657
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 18 at 4:24 AM
$ATRC Current Stock Price: $32.96 Contracts to trade: $40.0 ATRC Feb 20 2026 Call Entry: $0.19 Exit: $0.26 ROI: 36% Hold ~27 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
yousef112
yousef112 Feb. 17 at 10:14 PM
$ATRC Friday or next week, less than $30
0 · Reply
yousef112
yousef112 Feb. 17 at 9:41 PM
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 17 at 9:08 PM
$ATRC Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.04 up 112.12% YoY • Reported revenue of $140.5M up 13.05% YoY • AtriCure projects full year 2026 revenue of $600M to $610M, reflecting 12% to 14% growth, with adjusted EBITDA of $80 million to $82 million, and adjusted EPS of $0.09 to $0.15.
0 · Reply
Estimize
Estimize Feb. 17 at 4:00 PM
$ATRC reports after the close, Estimize Consensus -0.02 EPS and +1.43M Revs compared to WS http://www.estimize.com/atrc/fq4-2025?utm_conten
0 · Reply
SentimentIQ
SentimentIQ Feb. 4 at 1:34 PM
$ATRC is a medical device company in the wound care segment; its growth relies on converting clinicians to its negative pressure therapy systems in a competitive market.
0 · Reply